[HTML][HTML] Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

EM Ginzler, MA Dooley, C Aranow… - … England Journal of …, 2005 - Mass Medical Soc
Background Since anecdotal series and small, prospective, controlled trials suggest that
mycophenolate mofetil may be effective for treating lupus nephritis, larger trials are …

Common scientific and statistical errors in obesity research

BJ George, TM Beasley, AW Brown, J Dawson… - …, 2016 - Wiley Online Library
This review identifies 10 common errors and problems in the statistical analysis, design,
interpretation, and reporting of obesity research and discuss how they can be avoided. The …

[HTML][HTML] Combined oral contraceptives in women with systemic lupus erythematosus

M Petri, MY Kim, KC Kalunian… - … England Journal of …, 2005 - Mass Medical Soc
Background Oral contraceptives are rarely prescribed for women with systemic lupus
erythematosus, because of concern about potential negative side effects. In this double …

The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial

JP Buyon, MA Petri, MY Kim, KC Kalunian… - Annals of internal …, 2005 - acpjournals.org
Background: There is concern that exogenous female hormones may worsen disease
activity in women with systemic lupus erythematosus (SLE). Objective: To evaluate the effect …

Predictors of pregnancy outcomes in patients with lupus: a cohort study

JP Buyon, MY Kim, MM Guerra, CA Laskin… - Annals of internal …, 2015 - acpjournals.org
Background: Because systemic lupus erythematosus (SLE) affects women of reproductive
age, pregnancy is a major concern. Objective: To identify predictors of adverse pregnancy …

Maternal use of hydroxychloroquine is associated with a reduced risk of recurrent anti-SSA/Ro-antibody–associated cardiac manifestations of neonatal lupus

PM Izmirly, N Costedoat-Chalumeau, CN Pisoni… - Circulation, 2012 - Am Heart Assoc
Background—A recent case-control study suggested a benefit of hydroxychloroquine (HCQ)
in lowering the risk of cardiac manifestations of neonatal lupus (cardiac-NL) in pregnancies …

Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study

DM Friedman, MY Kim, JA Copel, C Davis… - Circulation, 2008 - Am Heart Assoc
Background—Anti-SSA/Ro–associated third-degree congenital heart block is irreversible,
prompting a search for early markers and effective therapy. Methods and Results—One …

Maternal and fetal factors associated with mortality and morbidity in a multi–racial/ethnic registry of anti-SSA/Ro–associated cardiac neonatal lupus

PM Izmirly, A Saxena, MY Kim, D Wang, SK Sahl… - Circulation, 2011 - Am Heart Assoc
Background—Cardiac manifestations of neonatal lupus include conduction disease and,
rarely, an isolated cardiomyopathy. This study was initiated to determine the mortality and …

Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus …

PM Izmirly, MY Kim, C Llanos, PU Le… - Annals of the …, 2010 - ard.bmj.com
Background Based on the potential involvement of Toll-like receptor (TLR) signalling in the
pathogenesis of neonatal lupus (NL), it was hypothesised that fetal exposure to …

Evaluation of immune response and disease status in systemic lupus erythematosus patients following SARS–CoV‐2 vaccination

PM Izmirly, MY Kim, M Samanovic… - Arthritis & …, 2022 - Wiley Online Library
Objective To evaluate seroreactivity and disease flares after COVID‐19 vaccination in a
multiethnic/multiracial cohort of patients with systemic lupus erythematosus (SLE). Methods …